SGMO - Sangamo TherapeuticsAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $11.44 | Open | $11.48 |
| Volume | 2.14M | Market Cap | 1.09B |
| Yield | Last Dividend |
| Sangamo Therapeutics Announces Participa... | 05/29/20 |
| BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present... | |
| Sangamo Therapeutics Announces Participa... | 05/12/20 |
| BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present... | |
| Sangamo Therapeutics (SGMO) Reports Q1 L... | 05/11/20 |
| Sangamo (SGMO) delivered earnings and revenue surprises of -60.87% and -57.78%, respectively, for the quarter ended March 2020. Do the numbers hold cl... | |
| Sangamo Therapeutics Reports Business Hi... | 05/11/20 |
| BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today reported first quarter 2020 financial ... | |
| Is Sangamo Therapeutics (SGMO) Stock Out... | 05/05/20 |
| Is (SGMO) Outperforming Other Medical Stocks This Year? | |
| Sangamo Therapeutics Announces First Qua... | 05/04/20 |
| BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the Company has schedul... | |
| Sangamo Therapeutics Announces Presentat... | 04/28/20 |
| BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced the acceptance of several ab... | |
| Mogrify strikes deal with US biopharma S... | 04/27/20 |
| The companies have announced a collaboration and licence agreement. | |
| Mogrify and Sangamo announce collaborati... | 04/21/20 |
| CAMBRIDGE, England & BRISBANE, Calif.--(BUSINESS WIRE)--Mogrify Ltd (Mogrify??), a UK company aiming to transform the development of cell therapies by... | |
| Sangamo Therapeutics and Biogen Announce... | 02/27/20 |
| The partnership would focus on developing treatments for neurological diseases. | |
| Sangamo +39% on gene therapy deal with B... | 02/27/20 |
| Sangamo Therapeutics (NASDAQ:SGMO) is up 39.4% after hours following the signing of a gene therapy deal with Biogen (NASDAQ:BIIB). The two have agreed... | |
| Biogen and Sangamo Announce Global Colla... | 02/27/20 |
| CAMBRIDGE, Mass. & BRISBANE, Calif.--(BUSINESS WIRE)--Biogen Inc. (Nasdaq: BIIB) and Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine com... | |
| The Daily Biotech Pulse: Gilead Kicks Of... | 02/27/20 |
| The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs o... | |
| The Daily Biotech Pulse: Moderna Ships C... | 02/25/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) ... | |
| Earnings Preview: Sangamo Therapeutics (... | 02/20/20 |
| Sangamo (SGMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with t... | |
| Sangamo Therapeutics Appoints John Marke... | 02/12/20 |
| BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced the appointment of Dr. John ... | |
| Sangamo Therapeutics to Present at the 3... | 01/09/20 |
| BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that Sandy Macrae, CEO of Sa... | |
| Why Sangamo Therapeutics Stock Sank Toda... | 12/10/19 |
| Investors didn't like the preliminary results from an early-stage study. | |
| The Gene Therapy Names Moving On The Aud... | 12/03/19 |
| Gene therapy company Audentes Therapeutics Inc (NASDAQ: BOLD ) announced a deal late Monday to be acquired by Japanese pharma company ASTELLAS PHARMA/... | |
| Sangamo Therapeutics Appoints James R. M... | 11/26/19 |
| BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced the appointment of James R. ... | |
| Sangamo Therapeutics Announces Participa... | 11/18/19 |
| BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present... | |
| Sangamo Biosciences Inc (SGMO) Q3 2019 E... | 11/07/19 |
| SGMO earnings call for the period ending September 30, 2019. | |
| Sangamo Therapeutics Announces Third Qua... | 10/30/19 |
| BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the Company has schedul... | |
| Sangamo Therapeutics News: SGMO Stock Su... | 07/08/19 |
| Sangamo Therapeutics (NASDAQ:SGMO) stock was on the up and up to kick off the week as the business revealed that it has made some key forward progress... | |
| Sangamo Therapeutics finance chief bids ... | 05/14/19 |
| No summary available. | |
| Here's Why Sangamo Therapeutics Fell as ... | 05/09/19 |
| The biopharma announced first-quarter 2019 operating results. | |
| Edited Transcript of SGMO earnings confe... | 05/08/19 |
| Q1 2019 Sangamo Therapeutics Inc Earnings Call | |
| Sangamo Therapeutics, Inc. (SGMO) CEO Sa... | 05/08/19 |
| Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2019 Earnings Conference Call May 08, 2019 05:00 PM ET Company Participants McDavid Stilwell - Vice Presid... | |
| What You Need to Know About Sangamo Ther... | 05/08/19 |
| The biotech's revenue fell. But it still managed to beat the consensus Wall Street earnings estimate. | |
| Sangamo Therapeutics, Inc. 2019 Q1 - Res... | 05/08/19 |
| No summary available. | |
| Date | 2020-05-11 (AMC) | Est. (EPS/Rev.) | ($0.29)/ 22.74M |
| Actual (EPS/Rev.) | $-0.37/ $13.08 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Write put options! | R. belegger | 84.00 % | Subscribe |
| Big Data Zhou | Zhou Academy | 81.00 % | Subscribe |
| Stocks and Options | Dr. Rao | 50.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
